These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3509139)
21. Variable furosemide absorption and poor predictability of response in elderly patients. Murray MD; Haag KM; Black PK; Hall SD; Brater DC Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769 [TBL] [Abstract][Full Text] [Related]
22. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
23. Comparative bioavailability of two furosemide formulations in humans. Martin BK; Uihlein M; Ings RM; Stevens LA; McEwen J J Pharm Sci; 1984 Apr; 73(4):437-41. PubMed ID: 6726624 [TBL] [Abstract][Full Text] [Related]
24. Implications of intraindividual variability in bioavailability studies of furosemide. Grahnén A; Hammarlund M; Lundqvist T Eur J Clin Pharmacol; 1984; 27(5):595-602. PubMed ID: 6519165 [TBL] [Abstract][Full Text] [Related]
25. Evaluating bioequivalence of meloxicam tablets: is in-vitro dissolution test overdiscriminating? Jin C; Zhao C; Shen D; Dong W; Liu H; He Z J Pharm Pharmacol; 2018 Feb; 70(2):250-258. PubMed ID: 29193077 [TBL] [Abstract][Full Text] [Related]
26. An in-vivo-in-vitro correlation for the bioavailability of frusemide tablets. Kingsford M; Eggers NJ; Soteros G; Maling TJ; Shirkey RJ J Pharm Pharmacol; 1984 Aug; 36(8):536-8. PubMed ID: 6148397 [TBL] [Abstract][Full Text] [Related]
27. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations. Ozdemir N; Ordu S; Ozkan Y Drug Dev Ind Pharm; 2000 Aug; 26(8):857-66. PubMed ID: 10900542 [TBL] [Abstract][Full Text] [Related]
28. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials. Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124 [TBL] [Abstract][Full Text] [Related]
29. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation. Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510 [TBL] [Abstract][Full Text] [Related]
30. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs. Koh SK; Jeong JW; Choi SI; Kim RM; Koo TS; Cho KH; Seo KW BMC Vet Res; 2021 Sep; 17(1):295. PubMed ID: 34488750 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, pharmacodynamics, and comparative bioavailability of single, oral 2-mg doses of dexamethasone liquid and tablet formulations: a randomized, controlled, crossover study in healthy adult volunteers. Queckenberg C; Wachall B; Erlinghagen V; Di Gion P; Tomalik-Scharte D; Tawab M; Gerbeth K; Fuhr U Clin Ther; 2011 Nov; 33(11):1831-41. PubMed ID: 22047811 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Hammarlund MM; Paalzow LK; Odlind B Eur J Clin Pharmacol; 1984; 26(2):197-207. PubMed ID: 6723758 [TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of a monolithic floating dosage form for furosemide. Menon A; Ritschel WA; Sakr A J Pharm Sci; 1994 Feb; 83(2):239-45. PubMed ID: 8169797 [TBL] [Abstract][Full Text] [Related]
36. Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations. Fontes-Ribeiro C; Nunes T; Falcão A; Neta C; Lima R; Tavares S; Almeida L; Macedo T; Soares-da-Silva P Drugs R D; 2005; 6(5):253-60. PubMed ID: 16128595 [TBL] [Abstract][Full Text] [Related]
37. Desorption of furosemide from charcoal in vitro and in man. Roivas L; Kivistö KT; Neuvonen PJ Int J Clin Pharmacol Ther; 1994 Jul; 32(7):365-9. PubMed ID: 7952799 [TBL] [Abstract][Full Text] [Related]
38. Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers. Maanen Rv; Bentley D Clin Ther; 2009 Jun; 31(6):1244-55. PubMed ID: 19695391 [TBL] [Abstract][Full Text] [Related]
39. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers. Ahmad M; Pervaiz F Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997 [TBL] [Abstract][Full Text] [Related]
40. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions. Elshafeey AH; Elsherbiny MA; Fathallah MM Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]